缓解期

  • 网络remission;remission stage;in remission;remissive stage;Remission phase
缓解期缓解期
  1. 缓解期仍存在免疫失衡为主,免疫低下相对少见。

    Remission remain immune imbalance mainly immunocompromised relatively rare .

  2. 祛毒胶囊治疗系统性红斑狼疮(缓解期)的理论与实验机理研究

    Dispels Poisonous Capsule in the Treatment of Systemic Lupus Erythematosus ( Remission ) Theoretical and Experimental Study on the Mechanism

  3. 在缓解期,T淋巴细胞的DNA体外合成能力明显增强,甚至略高于正常水平。

    When remission , the rate of DNA synthesis increased evidently .

  4. 治疗缓解期上述指标均有不同程度的恢复,但与正常人相比仍有差异(P<0.05)。

    In remission stage all the changes recovered in different degree but were still abnormal .

  5. 其中哮喘急性发作期组34例(3d内无静脉或口服激素史);哮喘缓解期组30例;

    34 patients were in the acute episode and 30 in remission ;

  6. 哮喘缓解期儿童血清白细胞介素-13与免疫球蛋白E水平变化

    Changes of Serum Interleukin-13 and Total Immunoglobulin E in Children with Stable Asthma

  7. 缓解期哮喘患儿及其父母血清总免疫球蛋白E水平变化

    Changes of Total Immunoglobulin E Concentration in Serum of Children with Asthma and Their Parents

  8. 处于MS急性复发期患者的血清尿酸水平低于缓解期患者(P<0.05)。

    MS patients had lower serum uric acid levels at relapse stage (( P < ) 0.05 ) .

  9. COPD缓解期患者阈压力负荷吸气肌锻炼的疗效观察

    Effects of threshold loading device for inspiratory muscles training in patients with COPD

  10. 舒利迭吸入剂对COPD患者缓解期治疗的疗效

    Seretide inhalation in the treatment of COPD patients in remission period of clinical observation

  11. 老年COPD、肺心病缓解期患者呼吸体操锻炼的效果

    Effects of breathing exercise on elderly with COPD and cor pulmonale patients in paracmasis

  12. 缓解期COPD病人肺功能与动脉血气的关系探讨

    Relationship between pulmonary functions and arterial blood gas in patients with COPD in remission stage

  13. 联用吸入型糖皮质激素和长效β2-受体激动剂在COPD缓解期治疗中的疗效观察

    Efficacy of inhaled glucocorticoids and long-acting beta 2-agonist 's inhalation in patients with stable COPD

  14. 无创双水平正压通气对缓解期COPD患者气道阻力的影响

    The Influence of Noninvasive Bi-level Positive Airway Pressure in Stable COPD Patients ' Respiratory Impedance

  15. 哮喘患儿急性期血浆cAMP明显低于缓解期和对照组(P均<0.01)。

    Plasma cAMP levels in acute attack stage were obviously lower than those in restoration stage and in normal group ( P < 0.01 );

  16. 结论中重度COPD缓解期患者使用天晴速乐及舒利迭联合吸入治疗可提高疗效,改善预后。

    Conclusion The combination of Tiotropium and Scrctidc in patients with severe COPD can improve the efficacy .

  17. COPD患者急性期与缓解期免疫指标变化的临床研究

    The Clinical Research on the Changes in Immunization Indicators of the COPD Patients in Acute Phase and Remission

  18. 肾病综合征缓解期和健康对照者无明显差中国差别(P>0.05)。中国差别的实行可使我们从另一个角度来了解美国的对华政策。

    There were not any differences in serum and urine SJL-2R concentrations between non-nephrotic stage group and healthy controls ( P > 0 . 05 ) . China policy from another aspect .

  19. 缓解期哮喘患者血清Clara细胞分泌蛋白水平研究

    Study on serum Clara cell secreted protein concentrations in stable asthmatics

  20. 30例肺心病患者急性加重期和临床缓解期血PaO2的测定采用动脉血气分析。

    PaO_2 were detected by arterial blood gas assay .

  21. 缓解期AML患者GATA2的表达与初治复发AML相比,差异无显著性;

    GATA 2 expression in remission patients was similar to newly diagnosed or relapsed patients .

  22. 10例AL第一次缓解期(CR1)的患者进入研究。

    Ten AL patients of complete remission at the first time ( CR ? 1 ) were enrolled .

  23. 目的:评价干扰素α(IFNα)和白细胞介素2(IL-2)联合激活的白血病缓解期骨髓对白血病细胞(K562细胞)的杀伤作用。

    Objective : To evaluate the killing effect of IL 2 and IFN α activated bone marrow cells on K562 cells .

  24. 10例慢性支气管炎缓解期患者和10例正常人的肺泡巨噬细胞(AM),加用LPS体外培养。

    Alveolar macrophages ( AM ) obtained from 12 chronic bronchitis alleviation patients and 12 normal subjects were cultured with LPS .

  25. 加味青蒿鳖甲汤对急性白血病缓解期患者骨髓细胞CD抗原表达及增殖的影响

    Acute Leukemia Bone Marrow Cells in Remission 's Patients with CD Antigen Expression and the Affect of Proliferation by Modified Preparation of Qing Hao Bie Jia Soup

  26. 方法:缓解期哮喘病人40例,随机分为A,B2组,每组各20例。

    METHODS : Forty patients with stable asthma were randomly divided into A and B group .

  27. 哮喘发作期PMN-CL明显高于缓解期(P<0.01),缓解期高于正常对照(P<0.05)。

    The PMN-CL in stage of attack was significantly higher than in stage of remission ( P < 0 . 01 ), the latter was higher than that in healthy subjects ( P < 0.05 ) .

  28. 目的从基因和蛋白质水平了解哮喘缓解期患儿T辅助淋巴细胞(Th)免疫平衡状况。

    Objective To evaluate the balance of Th1 / Th2 cells in the period of remission stage of asthma from the aspects of genes and protein .

  29. 目的:观察哮喘患者发作期与缓解期血浆中血管活性肠肽(VIP)水平改变,以探讨VIP在哮喘发病中的可能作用。

    Plasma VIP level changes during exacerbation and remission of asthma were derter-mined to investig its possible role in pathogenesis .

  30. 目的观察综合行为干预对缓解期慢性阻塞性肺病(COPD)患者生命质量的影响。

    Objective To observe the effects of general behavior intervention on quality of life for chronic obstructive pulmonary disease ( COPD ) patients .